China Health Group (HKSE:00673) Tariff Resilience Score: 0/10 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00673 China Health Group Ltd HKSE:00673
24 GF Score
Price HK$0.30
GF Value HK$0.24
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is China Health Group Tariff Resilience Score?

China Health Group has the Tariff Resilience Score of 0, which implies that the company might have .

China Health Group has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes China Health Group might have .

China Health Group  (HKSE:00673) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

China Health Group Tariff Resilience Score Related Terms

HKSE:00673
24GF Score
China Health Group Ltd HKSE:00673
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is China Health Group (HKSE:00673) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Group stock appears to be overvalued. The current stock price of HK$0.30 is trading 22.9% above its estimated GF Value™ of HK$0.24. GuruFocus considers China Health Group to be Modestly Overvalued.

Key valuation signals for HKSE:00673:

  • Tariff Resilience Score: 0
  • GF Value™: HK$0.24 vs. price of HK$0.30 (22.9% above fair value)
  • GF Score™: 24/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00673 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Health Group Business Description

Address 141 Des Voeux Road, Unit 801, 8th Floor, China Insurance Group Building, Central, Hong Kong, HKG
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management services, and business factoring. It operates in the business in four segments: medical equipment and consumables distribution and service business; hospital operation and management services business; business service; and research and development and sale of functional food. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically, the group derives its revenue from the PRC.
24GF Score

Get the complete analysis for HKSE:00673

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.30
Price
HK$0.24
GF Value